关注
Stephen F Carter
Stephen F Carter
University of Cambridge, University of Manchester (honorary)
在 medschl.cam.ac.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG
SF Carter, M Schöll, O Almkvist, A Wall, H Engler, B Långström, ...
Journal of Nuclear Medicine 53 (1), 37-46, 2012
4562012
Positron emission tomography imaging in dementia
K Herholz, SF Carter, M Jones
British Institute of Radiology, 2007
3202007
Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer’s disease
E Rodriguez-Vieitez, L Saint-Aubert, SF Carter, O Almkvist, K Farid, ...
Brain 139 (3), 922-936, 2016
2862016
Astrocyte biomarkers in Alzheimer’s disease
SF Carter, K Herholz, P Rosa-Neto, L Pellerin, A Nordberg, ER Zimmer
Trends in molecular medicine 25 (2), 77-95, 2019
2632019
A European multicentre PET study of fibrillar amyloid in Alzheimer’s disease
A Nordberg, SF Carter, J Rinne, A Drzezga, DJ Brooks, R Vandenberghe, ...
European journal of nuclear medicine and molecular imaging 40 (1), 104-114, 2013
2232013
Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease
A Prestia, A Caroli, WM van der Flier, R Ossenkoppele, B Van Berckel, ...
Neurology 80 (11), 1048-1056, 2013
2142013
Imaging biomarkers in neurodegeneration: current and future practices
PNE Young, M Estarellas, E Coomans, M Srikrishna, H Beaumont, ...
Alzheimer's research & therapy 12, 1-17, 2020
1632020
Mild cognitive impairment with suspected nonamyloid pathology (SNAP): prediction of progression
A Caroli, A Prestia, S Galluzzi, C Ferrari, WM Van Der Flier, ...
Neurology 84 (5), 508-515, 2015
1512015
Early astrocytosis in autosomal dominant Alzheimer’s disease measured in vivo by multi-tracer positron emission tomography
M Schöll, SF Carter, E Westman, E Rodriguez-Vieitez, O Almkvist, ...
Scientific reports 5, 16404, 2015
1362015
Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics
A Prestia, A Caroli, SK Wade, WM Van Der Flier, R Ossenkoppele, ...
Alzheimer's & Dementia 11 (10), 1191-1201, 2015
1012015
Astrocyte biomarkers in Alzheimer disease: a systematic review and meta-analysis
B Bellaver, JP Ferrari-Souza, L Uglione da Ros, SF Carter, ...
Neurology 96 (24), e2944-e2955, 2021
852021
Staging of the cognitive decline in Alzheimer's disease: insights from a detailed neuropsychological investigation of mild cognitive impairment and mild Alzheimer's disease
SF Carter, D Caine, A Burns, K Herholz, MA Lambon Ralph
International journal of geriatric psychiatry 27 (4), 423-432, 2012
802012
Comparison of early-phase 11C-deuterium-l-deprenyl and 11C-Pittsburgh compound B PET for assessing brain perfusion in Alzheimer disease
E Rodriguez-Vieitez, SF Carter, K Chiotis, L Saint-Aubert, A Leuzy, ...
Journal of Nuclear Medicine 57 (7), 1071-1077, 2016
782016
Use of amyloid-PET to determine cutpoints for CSF markers A multicenter study
MD Zwan, JO Rinne, SG Hasselbalch, A Nordberg, A Lleó, SK Herukka, ...
Neurology 86 (1), 50-58, 2016
732016
Relevance of biomarkers across different neurodegenerative diseases
AJ Ehrenberg, A Khatun, E Coomans, MJ Betts, F Capraro, EH Thijssen, ...
Alzheimer's research & therapy 12, 1-11, 2020
672020
Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET
P Edison, SF Carter, JO Rinne, G Gelosa, K Herholz, A Nordberg, ...
Neuroimage 70, 423-433, 2013
672013
Astrocytosis measured by 11C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer’s patients
ILH Choo, SF Carter, ML Schöll, A Nordberg
European journal of nuclear medicine and molecular imaging 41 (11), 2120-2126, 2014
652014
The EMIF-AD PreclinAD study: study design and baseline cohort overview
E Konijnenberg, SF Carter, M Ten Kate, A Den Braber, J Tomassen, ...
Alzheimer's research & therapy 10, 1-12, 2018
572018
Concordance and Diagnostic Accuracy of [11 C] PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease
A Leuzy, SF Carter, K Chiotis, O Almkvist, A Wall, A Nordberg
Journal of Alzheimer's Disease, 2015
492015
Longitudinal association between astrocyte function and glucose metabolism in autosomal dominant Alzheimer’s disease
SF Carter, K Chiotis, A Nordberg, E Rodriguez-Vieitez
European Journal of Nuclear Medicine and Molecular Imaging 46, 348-356, 2019
462019
系统目前无法执行此操作,请稍后再试。
文章 1–20